“Artificial Intelligence has been increasingly used to support diagnosis in the most different health treatments and, in times of a pandemic such as that caused by the coronavirus, using it is essential. Our role in this partnership goes beyond the collaboration of exams for this large database. In recent years, we have advanced in the application of AI for different types of diagnostic tests. In this way, we are also available to collaborate with all our AI expertise in this partnership in favor of the population.”

Dr. Gustavo Meirelles, radiologist and clinical manager of Innovaetion at Grupo Fleury

“We are very happy to support this research initiative that creates an algorithm to accelerate the outcome of patients suspected of having pulmonary involvement by COVID-19. We believe it is an important part in fighting the virus, since the report helps to indicate the potential positive cases for the virus and, as a consequence, streamlines the results while reducing the margin of error in the diagnosis. UnitedHealth Group Brasil will offer a wide range of cases that permeate its 35 hospitals, hundreds of exams, in addition to the expertise of a team of radiologists specialized in the chest.”

Dr. Conrado Cavalcanti, Coordinator of Diagnostic and Therapeutic Medicine at UnitedHealth Group Brazil.

“It is CBR’s commitment to work together with the institutions, uniting all radiologists in Brazil in favor of actions involving the fight against COVID-19. In the case of the launch of the RadVid19 platform, which focuses on research, the contribution to the radiological community is of great value. We count on the participation of all radiologists in the use and dissemination of this important tool.”

Dr. Valdair Muglia, scientific director at CBR.

“The partnership which Sírio-Libanês is part of will allow the use of lung tomography data to make diagnoses in hospitalized patients. The system will identify Covid-19 indications, and differentiate the diagnosis from other pathologies, such as pneumonia, for example. Today, diagnostic methods include PCR secretion examination, which is not available throughout Brazil; a quick blood test method, which has less sensitivity; and this new model. After determining the effectiveness of this software, the model will be sent to the Federal Government, which may choose to disseminate its use throughout the country. This methodology could help regions that do not have radiologists 24 hours a day, or that do not have lung specialists to carry out reports.”

Dr. Cesar Nomura is director of Diagnostic Medicine at Sírio-Libanês.

“In the face of such a challenging scenario, collaboration and access to knowledge enhanced by AI technologies bring us powerful agility amid the brilliant performance of medical professionals, resulting in a potential chance to save more lives.”

Paulo Banevicius, Director of the Enterprise Digital Solutions Division at GE Healthcare.

“Deloitte believes in Artificial Intelligence (AI) as a transforming element of Health. So much so that we are together with InRad / InovaHC and its partners in the program to combat Covid-19, supporting the strategy, advisory and governance of the project. We are absolutely convinced that this initiative will result not only in great socioeconomic impact, but also in the promotion of Brazilian Science and Technology and, above all, in the transformation of medicine in Brazil. This journey will accelerate the training of young medical engineers and will allow Brazil to be positioned at the frontier of the global knowledge of AI applied to Health.”

Marcia Ogawa Matsubayashi, Leading Partner Technology, Media and Telecommunications at Deloitte Brasil.

“AWS continues its commitment to support innovative initiatives for the best health in our country. In addition to making our services available, we are all united in directing all our efforts to help during the fight against COVID-19. In an extremely delicate moment like this, it is initiatives like that of HC which give us hope that together we will fight this pandemic.”

Paulo Cunha, Public Sector Leader AWS Brasil.

“The Novartis Foundation recognizes that data analysis and artificial intelligence are essential in our mission to transform the health of populations and the provision of healthcare. Our aspiration in this collaboration with Hospital das Clínicas is to create a use case for how artificial intelligence models can serve the public hospital sector in Brazil. We hope that this important work on the detection of Covid-19 will help to encourage more innovation “Made in Brazil” in the strategic areas of the Care, Teaching and Research hospital. ”

Ann Aerts, Head Novartis Foundation.

“Our purpose of generating impact on social innovation in wide scale through design gains new power with the use of Artificial Intelligence in partnership with Hospital das Clínicas, especially in this very challenging and important moment that the Covid-19 Pandemic brings us. This project is an example of how collaboration can leave a transformative legacy for society by saving lives and taking health technology in Brazil to a new level.”

Germano Guimarães, President Director Instituto Tellus.

“Radvid-19 is the type of initiative that we believe to be relevant and urgent and, therefore, we are proud to support: the project demonstrates the potential of innovation by bringing solutions to relevant challenges such as helping to cope with COVID-19. In addition, it shows how the union of efforts between the public and private sectors brings broad benefits. For doctors, it is a powerful tool for increasing the speed and accuracy of a diagnosis; for the patient, it is another step towards an effective treatment; and for managers of hospitals and health systems, it represents the opportunity to use existing resources more efficiently. With the expansion, we see an even wider reach of the positive impacts of this initiative”.

Morgan Doyle, IDB representative in Brazil.